GlobeNewswire

Nasdaq Agrees to Sell BWise® to SAI Global

Del

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) announced today that it has entered into an agreement to sell BWise® to SAI Global Pty Limited (“SAI Global”), a recognized leader of integrated risk management solutions. The closing of this transaction is subject to regulatory approvals, works council and other representative body consultations and notifications in applicable jurisdictions, and customary closing conditions, and is projected to occur in the first half of 2019.

BWise is an enterprise governance, risk and compliance (GRC) software platform established in 1994 and acquired by Nasdaq in 2012. Its enterprise GRC software platform and Risk Intelligence services and solutions help companies drive process efficiencies, enhance accountability, and reduce costs, resulting in improved decision making within an organization’s Enterprise Risk Management program. These solutions support companies of all sizes with operational risk management, internal audit, internal control, compliance, and information security programs.

SAI Global helps organizations proactively manage risk to create trust and achieve business excellence, growth, and sustainability. The company’s integrated risk management solutions operate across their customers’ entire risk lifecycle, thereby offering a strategic alignment opportunity with the BWise product suite.

“This transaction is a result of Nasdaq’s renewed corporate strategy to concentrate our resources, people, and capital to maximize our potential as a technology and analytics provider to the capital markets, while also investing to enhance our leading marketplaces and the capital market clients we serve,” said Adena Friedman, President and CEO, Nasdaq. “SAI Global is the right partner for BWise, and we are confident in their ability to ensure BWise’s clients continue to receive excellent customer service and even more comprehensive risk and compliance services and solutions in the future.”

As Nasdaq concentrates the solutions it offers to corporate clients globally, it is focused on maximizing the benefits our clients receive from our capital markets and governance expertise, coupled with our analytics and technology capabilities. In that regard, in addition to providing successful access to capital markets with our world-class exchanges in the U.S. and Europe, Nasdaq is dedicated to providing our corporate clients with strategic C-Suite and board solutions that provide investor relations intelligence and governance insights and collaboration. 

“We are excited about having SAI Global as our new partner and look forward to being able to accelerate our strategic vision as we continue to serve our clients amidst a fast-changing risk and compliance landscape,” said Jonathan Deeks, CEO, BWise. “By joining forces with SAI Global, we have a unique opportunity to drive change at a massive scale and reshape the industry.”

Until the closing of the transaction, SAI Global and BWise will continue to operate as independent companies and will remain committed to providing superior service to create value for their customers.

About Nasdaq:

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 100 marketplaces in 50 countries. Nasdaq is home to approximately 4,000 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com.

Forward-Looking Statements:

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including statements with respect to the sale by Nasdaq of BWise, the benefits and timing of the transaction and Nasdaq’s products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Nasdaq Media Relations Contact:

Will Briganti
+1 (678) 504-6097
william.briganti@nasdaq.com 

Nasdaq Investor Relations Contact:

Ed Ditmire, CFA
+1 (212) 401-8737
ed.ditmire@nasdaq.com  

-NDAQF-

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals19.2.2019 09:00:00Pressemelding

The High Court also found Sinopharm Weiqida guilty of Contempt of Court for failing to follow the previously granted preliminary injunction order ROTTERDAM, the Netherlands, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals, announced that the Delhi High Court in India has granted an injunction against Sinopharm Weiqida Pharmaceuticals and Sinopharm India, restricting the export and/or import into India of its active pharmaceutical ingredient (API) amoxicillin trihydrate. In addition, the Delhi High Court also found Sinopharm Weiqida prima facie guilty of contempt of Court for illegally importing amoxicillin active ingredients in contravention of the previously granted preliminary injunction in place in India since April 2017. The Court further found that Sinopharm Weiqida has infringed the patent of Centrient. Centrient, and its wholly owned subsidia

New Milestone for Cansativa Towards “EU GxP Innovation Hub”19.2.2019 07:15:00Pressemelding

Northern Swan invests millions in pharma startup Cansativa FRANKFURT, Germany, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in order to further accelerate the growth of the company and its integration into the wider European market. Cansativa will use this investment to expand its current facilities to become a “EU GxP Innovation Hub” and fulfillment center for medical cannabis. This way, Cansativa helps promote the professionalization of the entire medical cannabis industry in Europe from its location in Frankfurt am Main, Germany. The new site will serve as the EU hub for the growing industry, granting pharmaceutical companies from all over the world access to the rapidly growing European market. Cansativa is poised to lend its support as a reliable, independent full-service GxP partner. "Unlike the majority of our competitors, we operate independently of third-party contractors – Ever since w

Juniper Systems Limited Launches New Cedar CT8 Rugged Tablet19.2.2019 05:16:00Pressemelding

Fully-Rugged Tablet Provides Global Connectivity, Better Performance BIRMINGHAM, United Kingdom, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Juniper Systems Limited today announced the release of the Cedar CT8™ Rugged Tablet, a high-performance Android® tablet made for rugged environments. The CT8 – the third Cedar tablet from Juniper Systems™ – marks a major upgrade in performance and GPS capability from its predecessor, the Cedar CT7G Rugged Tablet (2017 release). Packed behind its 8-inch high-visibility display is a Qualcomm Snapdragon 8-core processor running Android 8.1 with full Google® Mobile Services. This highly-efficient processor results in lower power consumption, less heat generated, and better overall performance. ‘The CT8 is fast, affordable, and it’s got rugged bones’, said Cody Draper, Juniper Systems’ Cedar product manager. ‘Job sites that need a formidable, cost-effective rugged tablet will find the CT8’s features easily meet and exceed those needs’. The CT8 Rugged Tablet also

INVNT No Longer Involved, As Bethel Woods Music and Culture Festival Changes Direction and Becomes Three Separate Events18.2.2019 23:37:00Pressemelding

NEW YORK, NY, Feb. 18, 2019 (GLOBE NEWSWIRE) -- INVNT, the global live brand storytelling agency™ today announces that it will not be producing Bethel Woods Music and Culture Festival: Celebrating the golden anniversary at the historic site of the 1969 Woodstock festival. The festival, which was planned for August 16-18, 2019 at Bethel Woods Center for the Arts, will now comprise three separate events over three days, and forms part of the venue’s Season of Song & Celebration commemorations, a year-long schedule of exhibits, programs and events. Scott Cullather, CEO, INVNT explained that the agency is proud of its support and contributions to the celebration plans and the global awareness that its efforts brought to Bethel Woods Center for the Arts, as a result. "INVNT will not be involved in the new format and we wish Bethel Woods and Live Nation, as well as the organizers of the other 50th anniversary celebrations taking place around the world, the very best," he said. "Bethel Woods

Align Technology Launches New iTero Element 5D Imaging System for Comprehensive Preventative and Restorative Oral Care at IDS18.2.2019 12:00:00Pressemelding

SAN JOSE, Calif., Feb. 18, 2019 (GLOBE NEWSWIRE) -- First intraoral scanner with near-infrared imaging (NIRI) technology that scans the internal structure of a tooth (enamel & dentin) in real time1. First integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI, and enables comparison over time using iTero® TimeLapse1. NIRI technology of the iTero Element® 5D system aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1. New web-based interface MyiTero.com complements visualization of the iTero Element 5D system. Limited-release direct doctor-lab workflow automatically sends scan to lab of choice. Align Technology, Inc. (NASDAQ: ALGN) today announced that it is launching the iTero Element 5D Imaging System, which provides a new comprehensive approach to clinical applications, workflows and user experience that expands the suite of existing high-precision, full-color imaging and fast scan time

General Electric Company: Dividend Declaration18.2.2019 08:00:00Pressemelding

FAIRFIELD, Conn., Feb. 18, 2019 (GLOBE NEWSWIRE) -- GE Board of Directors Authorizes Regular Quarterly Dividend The Board of Directors of GE (NYSE: GE) today declared a $0.01 per share dividend on the outstanding common stock of the Company. The dividend is payable April 25, 2019 to shareowners of record at the close of business on March 11, 2019. The ex-dividend date is March 8, 2019. About GE GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE's mission and deliver for our customers. www.ge.com GE's Investor Relations website at www.ge.com/investor and our corporate b